Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)
NCT00508833
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B Disease
Interventions
BIOLOGICAL:
287615 containing HBsAg with adjuvants
Sponsor
GlaxoSmithKline